HomeCompareAMIH vs PFE

AMIH vs PFE: Dividend Comparison 2026

AMIH yields 250000.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AMIH wins by $4.567699004441311e+30M in total portfolio value
10 years
AMIH
AMIH
● Live price
250000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.567699004441311e+30M
Annual income
$4,564,107,688,187,857,300,000,000,000,000,000,000.00
Full AMIH calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — AMIH vs PFE

📍 AMIH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAMIHPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AMIH + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AMIH pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMIH
Annual income on $10K today (after 15% tax)
$21,250,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,879,491,534,959,678,500,000,000,000,000,000,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, AMIH beats the other by $3,879,491,534,959,678,500,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMIH + PFE for your $10,000?

AMIH: 50%PFE: 50%
100% PFE50/50100% AMIH
Portfolio after 10yr
$2.2838495022206556e+30M
Annual income
$2,282,053,844,093,928,700,000,000,000,000,000,000.00/yr
Blended yield
99.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

AMIH
No analyst data
Altman Z
-0.8
Piotroski
3/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMIH buys
0
PFE buys
0
No recent congressional trades found for AMIH or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAMIHPFE
Forward yield250000.00%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$4.567699004441311e+30M$49.6K
Annual income after 10y$4,564,107,688,187,857,300,000,000,000,000,000,000.00$26,258.71
Total dividends collected$4.567463897060879e+30M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AMIH vs PFE ($10,000, DRIP)

YearAMIH PortfolioAMIH Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$25,010,700$25,000,000.00$9,153$693.39+$25.00MAMIH
2$58,462,976,402$58,436,214,953.27$8,593$849.25+$58462.97MAMIH
3$127,722,124,784,416$127,659,569,399,665.92$8,336$1,066.78+$127722124.78MAMIH
4$260,784,910,907,288,130$260,648,248,233,768,800.00$8,437$1,384.80+$260784910907.28MAMIH
5$497,657,939,618,196,950,000$497,378,899,763,526,240,000.00$9,013$1,875.40+$497657939618196.94MAMIH
6$887,590,576,640,622,200,000,000$887,058,082,645,230,600,000,000.00$10,306$2,680.72+$887590576640622208.00MAMIH
7$1,479,547,418,610,237,200,000,000,000$1,478,597,696,693,231,600,000,000,000.00$12,820$4,101.38+$1.4795474186102372e+21MAMIH
8$2,305,052,548,351,757,200,000,000,000,000$2,303,469,432,613,844,500,000,000,000,000.00$17,673$6,826.70+$2.3050525483517572e+24MAMIH
9$3,356,370,330,330,650,300,000,000,000,000,000$3,353,903,924,103,914,000,000,000,000,000,000.00$27,543$12,591.86+$3.3563703303306504e+27MAMIH
10$4,567,699,004,441,311,000,000,000,000,000,000,000$4,564,107,688,187,857,300,000,000,000,000,000,000.00$49,560$26,258.71+$4.567699004441311e+30MAMIH

AMIH vs PFE: Complete Analysis 2026

AMIHStock

American International Holdings Corp., through its subsidiaries, operates as an investor, developer, and asset manager with assets in the healthcare supply chain. Its portfolio encompasses telemedicine and other virtual health platforms, subscriber based primary care and concierge medicine plans, preventative care solutions, and wellness related assets, such as mental and behavioral health services, as well as its own proprietary life coaching platform. The company offers its various services through direct-to-consumer and business-to-business distribution channels. American International Holdings Corp. was founded in 1986 and is headquartered in Plano, Texas.

Full AMIH Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this AMIH vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMIH vs SCHDAMIH vs JEPIAMIH vs OAMIH vs KOAMIH vs MAINAMIH vs JNJAMIH vs MRKAMIH vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.